Skip to main navigation

Corporate Menu & Investor Relations

Contact Patients

Mission Leadership Community

The TCR Complex Therapeutic Approach TRuC-T Advantages Manufacturing Publications

Overview TC-210 TC-110 Pipeline

Press Releases In the News Awards

Overview Events Presentations Corporate Governance SEC Filings Stock Information Analyst Coverage FAQs

Careers

Corporate Menu & Investor Relations

About Us Mission Leadership Community Technology The TCR Complex Therapeutic Approach TRuC-T Advantages Manufacturing Publications Programs Overview TC-210 TC-110 Pipeline News Press Releases In the News Awards Investors Overview Events Presentations Corporate Governance SEC Filings Stock Information Analyst Coverage FAQs Careers Careers Contact Patients

Events

Events

Upcoming Events

Oct 20, 2021

TCR<sup>2</sup> R&D Day

For details, please view the press release.

Past Events

Year

All Events | 2021 | 2020 | 2019 |

Sep 17, 2021 at 9:00 AM EDT

Interim Data from Ongoing Gavo-cel Phase 1/2 Clinical Trial

Supporting Materials

gavo-cel Phase 1/2 Clinical Update 1.6 MB

Sep 17, 2021 at 8:20 AM EDT

ESMO Congress 2021

Sep 13, 2021 at 7:00 AM EDT

H.C. Wainwright 23rd Annual Global Investment Conference

Jun 9, 2021 at 9:40 AM EDT

Fireside Chat at the Goldman Sachs 42nd Annual Global Healthcare Conference

Jun 2, 2021 at 2:30 PM EDT

Jefferies Virtual Healthcare Conference

May 5, 2021 at 11:20 AM EDT

7th Annual Truist Securities Life Sciences Summit

Apr 14, 2021 at 8:00 AM EDT

20th Annual Needham Virtual Healthcare Conference

Apr 10 - Apr 15, 2021

American Association for Cancer Research (AACR) Virtual Annual Meeting

Supporting Materials

Engineering Off-the-shelf T Cell Receptor Fusion Construct (TRuC) T Cells Targeting Mesothelin 3.9 MB

Discovery and Preclinical Characterization of Fratricide-resistant TRuC-T Cells Targeting CD70 723.4 KB

Preliminary Safety and Efficacy of gavocabtagene autoleucel (gavo-cel, TC-210), a T Cell Receptor Fusion Construct (TRuC®), in Patients with Treatment Refractory Mesothelin Overexpressing Solid Tumors 3.1 MB

Preliminary Safety and Efficacy of gavocabtagene autoleucel (gavo-cel, TC-210),…

Discovery and Preclinical Characterization of Fratricide-resistant TRuC-T Cells…

Engineering Off-the-shelf T Cell Receptor Fusion Construct (TRuC) T Cells Targe…

Mar 17, 2021 at 11:00 AM EDT

Fireside Chat at the 33rd Annual Roth Conference

Mar 9, 2021 at 7:00 AM EST

H.C. Wainwright Global Life Sciences Conference

Feb 24, 2021 at 8:00 AM EST

SVB Leerink Global Healthcare Conference

Jan 14, 2021 at 7:30 AM EST

39th Annual J.P. Morgan Healthcare Conference

Tools

Print Page
RSS Feeds
Email Alerts
Contact IR

100 Binney Street, Suite 710
Cambridge, MA 02142
617.949.5200

Corporate Menu & Investor Relations

About Us
Technology
Programs
News
Investors
Careers
Contact
Patients